Bioequivalence of Extended Release Nifedipine Tablets in Healthy Chinese Subjects
Status:
Recruiting
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
According to the relevant provisions of bioequivalence test, nifedipine sustained-release
tablets (test preparation, t, 30mg / tablet) provided by Guangzhou bostao controlled release
pharmaceutical Co., Ltd. were compared with Adalat ® GITS (reference preparation, R, 30mg /
tablet) produced by Bayer Pharma AG to evaluate the bioequivalence of single dose in healthy
subjects under fasting conditions.